US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist

0.083
-0.003-3.15%

Close Nov 1 16:00 ET

0.075
-0.008-9.75%

Post 19:57 ET

12.26MMarket Cap-22P/E (TTM)

CERo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

113.29%5.15M

2.41M

-30.97%2.44M

3.06%11.97M

3.53M

11.62M

Selling and administrative expenses

99.39%2.43M

--1.22M

-13.30%638.35K

-14.27%2.13M

--736.28K

--2.48M

-General and administrative expense

99.39%2.43M

--1.22M

-13.30%638.35K

-14.27%2.13M

--736.28K

--2.48M

Research and development costs

127.51%2.71M

--1.19M

-35.63%1.8M

7.76%9.85M

--2.8M

--9.14M

Operating profit

-113.29%-5.15M

-2.41M

30.97%-2.44M

-3.06%-11.97M

-3.53M

-11.62M

Net non-operating interest income expense

-128.57%-16.98K

59.42K

-99.91%16

-85.60%142.12K

17.27K

986.71K

Non-operating interest income

----

--59.42K

-99.91%16

-85.60%142.12K

--17.27K

--986.71K

Non-operating interest expense

--16.98K

----

Other net income (expense)

937.56%2.72M

261.82K

Gain on sale of security

1,007.62%2.9M

--261.82K

----

Special income (charges)

--447.34K

--0

----

-Less:Other special charges

---447.34K

----

Other non- operating income (expenses)

---630.78K

----

Income before tax

-17.02%-2.45M

-2.09M

30.64%-2.44M

-11.28%-11.83M

-3.52M

-10.63M

Income tax

Net income

-17.02%-2.45M

-2.09M

30.64%-2.44M

-11.28%-11.83M

-3.52M

-10.63M

Net income continuous Operations

-17.02%-2.45M

---2.09M

30.64%-2.44M

-11.28%-11.83M

---3.52M

---10.63M

Minority interest income

Net income attributable to the parent company

-17.02%-2.45M

-2.09M

30.64%-2.44M

-11.28%-11.83M

-3.52M

-10.63M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-17.02%-2.45M

-2.09M

30.64%-2.44M

-11.28%-11.83M

-3.52M

-10.63M

Basic earnings per share

34.78%-0.15

-0.23

30.64%-0.2689

-11.28%-1.3044

-0.3876

-1.1721

Diluted earnings per share

34.78%-0.15

-0.23

30.64%-0.2689

-11.28%-1.3044

-0.3876

-1.1721

Dividend per share

Currency Unit

USD

	(Q2)Jun 30, 2024	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	113.29%5.15M	2.41M	-30.97%2.44M	3.06%11.97M	3.53M	11.62M
Selling and administrative expenses	99.39%2.43M	--1.22M	-13.30%638.35K	-14.27%2.13M	--736.28K	--2.48M
-General and administrative expense	99.39%2.43M	--1.22M	-13.30%638.35K	-14.27%2.13M	--736.28K	--2.48M
Research and development costs	127.51%2.71M	--1.19M	-35.63%1.8M	7.76%9.85M	--2.8M	--9.14M
Operating profit	-113.29%-5.15M	-2.41M	30.97%-2.44M	-3.06%-11.97M	-3.53M	-11.62M
Net non-operating interest income expense	-128.57%-16.98K	59.42K	-99.91%16	-85.60%142.12K	17.27K	986.71K
Non-operating interest income	----	--59.42K	-99.91%16	-85.60%142.12K	--17.27K	--986.71K
Non-operating interest expense	--16.98K	----	----	----	----	----
Other net income (expense)	937.56%2.72M	261.82K
Gain on sale of security	1,007.62%2.9M	--261.82K	----	----	----	----
Special income (charges)	--447.34K	--0	--0	----	----	----
-Less:Other special charges	---447.34K	----	----	----	----	----
Other non- operating income (expenses)	---630.78K	----	----	----	----	----
Income before tax	-17.02%-2.45M	-2.09M	30.64%-2.44M	-11.28%-11.83M	-3.52M	-10.63M
Income tax
Net income	-17.02%-2.45M	-2.09M	30.64%-2.44M	-11.28%-11.83M	-3.52M	-10.63M
Net income continuous Operations	-17.02%-2.45M	---2.09M	30.64%-2.44M	-11.28%-11.83M	---3.52M	---10.63M
Minority interest income
Net income attributable to the parent company	-17.02%-2.45M	-2.09M	30.64%-2.44M	-11.28%-11.83M	-3.52M	-10.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-17.02%-2.45M	-2.09M	30.64%-2.44M	-11.28%-11.83M	-3.52M	-10.63M
Basic earnings per share	34.78%-0.15	-0.23	30.64%-0.2689	-11.28%-1.3044	-0.3876	-1.1721
Diluted earnings per share	34.78%-0.15	-0.23	30.64%-0.2689	-11.28%-1.3044	-0.3876	-1.1721
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data